These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1179 related items for PubMed ID: 30075794

  • 1. The added value of mammography in different age-groups of women with and without BRCA mutation screened with breast MRI.
    Vreemann S, van Zelst JCM, Schlooz-Vries M, Bult P, Hoogerbrugge N, Karssemeijer N, Gubern-Mérida A, Mann RM.
    Breast Cancer Res; 2018 Aug 03; 20(1):84. PubMed ID: 30075794
    [Abstract] [Full Text] [Related]

  • 2. Influence of Risk Category and Screening Round on the Performance of an MR Imaging and Mammography Screening Program in Carriers of the BRCA Mutation and Other Women at Increased Risk.
    Vreemann S, Gubern-Mérida A, Schlooz-Vries MS, Bult P, van Gils CH, Hoogerbrugge N, Karssemeijer N, Mann RM.
    Radiology; 2018 Feb 03; 286(2):443-451. PubMed ID: 29040037
    [Abstract] [Full Text] [Related]

  • 3. Breast cancer detection and tumor characteristics in BRCA1 and BRCA2 mutation carriers.
    Krammer J, Pinker-Domenig K, Robson ME, Gönen M, Bernard-Davila B, Morris EA, Mangino DA, Jochelson MS.
    Breast Cancer Res Treat; 2017 Jun 03; 163(3):565-571. PubMed ID: 28343309
    [Abstract] [Full Text] [Related]

  • 4. Triple-modality screening trial for familial breast cancer underlines the importance of magnetic resonance imaging and questions the role of mammography and ultrasound regardless of patient mutation status, age, and breast density.
    Riedl CC, Luft N, Bernhart C, Weber M, Bernathova M, Tea MK, Rudas M, Singer CF, Helbich TH.
    J Clin Oncol; 2015 Apr 01; 33(10):1128-35. PubMed ID: 25713430
    [Abstract] [Full Text] [Related]

  • 5. The supplemental value of mammographic screening over breast MRI alone in BRCA2 mutation carriers.
    Obdeijn IM, Mann RM, Loo CCE, Lobbes M, Voormolen EMC, van Deurzen CHM, de Bock G, Hereditary Breast Ovarian Cancer Research Group Netherlands (HEBON), Hooning MJ.
    Breast Cancer Res Treat; 2020 Jun 01; 181(3):581-588. PubMed ID: 32333294
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Evaluation of the Utility of Screening Mammography for High-Risk Women Undergoing Screening Breast MR Imaging.
    Lo G, Scaranelo AM, Aboras H, Ghai S, Kulkarni S, Fleming R, Bukhanov K, Crystal P.
    Radiology; 2017 Oct 01; 285(1):36-43. PubMed ID: 28586291
    [Abstract] [Full Text] [Related]

  • 8. Abnormal Findings Detected by Multi-modality Breast Imaging and Biopsy Results in a High-risk Clinic.
    Laitman Y, Feldman DM, Sklair-Levy M, Yosepovich A, Barshack-Nakar I, Brodsky M, Halshtok O, Shalmon A, Gotlieb M, Friedman E.
    Clin Breast Cancer; 2018 Aug 01; 18(4):e695-e698. PubMed ID: 29292184
    [Abstract] [Full Text] [Related]

  • 9. The clinical impact of MRI screening for BRCA mutation carriers: the first report in Japan.
    Murakami W, Tozaki M, Nakamura S, Ide Y, Inuzuka M, Hirota Y, Murakami K, Takahama N, Ohgiya Y, Gokan T.
    Breast Cancer; 2019 Sep 01; 26(5):552-561. PubMed ID: 30820924
    [Abstract] [Full Text] [Related]

  • 10. Should we screen BRCA1 mutation carriers only with MRI? A multicenter study.
    Obdeijn IM, Winter-Warnars GA, Mann RM, Hooning MJ, Hunink MG, Tilanus-Linthorst MM.
    Breast Cancer Res Treat; 2014 Apr 01; 144(3):577-82. PubMed ID: 24567197
    [Abstract] [Full Text] [Related]

  • 11. MRI and mammography surveillance of women at increased risk for breast cancer: recommendations using an evidence-based approach.
    Granader EJ, Dwamena B, Carlos RC.
    Acad Radiol; 2008 Dec 01; 15(12):1590-5. PubMed ID: 19000876
    [Abstract] [Full Text] [Related]

  • 12. Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imaging.
    Saadatmand S, Tilanus-Linthorst MM, Rutgers EJ, Hoogerbrugge N, Oosterwijk JC, Tollenaar RA, Hooning M, Loo CE, Obdeijn IM, Heijnsdijk EA, de Koning HJ.
    J Natl Cancer Inst; 2013 Sep 04; 105(17):1314-21. PubMed ID: 23940285
    [Abstract] [Full Text] [Related]

  • 13.
    Melnikow J, Fenton JJ, Whitlock EP, Miglioretti DL, Weyrich MS, Thompson JH, Shah K.
    ; 2016 01 04. PubMed ID: 26866210
    [Abstract] [Full Text] [Related]

  • 14. Breast cancer screening in BRCA1 and BRCA2 mutation carriers after risk reducing salpingo-oophorectomy.
    Fakkert IE, Jansen L, Meijer K, Kok T, Oosterwijk JC, Mourits MJ, de Bock GH.
    Breast Cancer Res Treat; 2011 Aug 04; 129(1):157-64. PubMed ID: 21373873
    [Abstract] [Full Text] [Related]

  • 15. The frequency of missed breast cancers in women participating in a high-risk MRI screening program.
    Vreemann S, Gubern-Merida A, Lardenoije S, Bult P, Karssemeijer N, Pinker K, Mann RM.
    Breast Cancer Res Treat; 2018 Jun 04; 169(2):323-331. PubMed ID: 29383629
    [Abstract] [Full Text] [Related]

  • 16. Multicenter surveillance of women at high genetic breast cancer risk using mammography, ultrasonography, and contrast-enhanced magnetic resonance imaging (the high breast cancer risk italian 1 study): final results.
    Sardanelli F, Podo F, Santoro F, Manoukian S, Bergonzi S, Trecate G, Vergnaghi D, Federico M, Cortesi L, Corcione S, Morassut S, Di Maggio C, Cilotti A, Martincich L, Calabrese M, Zuiani C, Preda L, Bonanni B, Carbonaro LA, Contegiacomo A, Panizza P, Di Cesare E, Savarese A, Crecco M, Turchetti D, Tonutti M, Belli P, Maschio AD, High Breast Cancer Risk Italian 1 (HIBCRIT-1) Study.
    Invest Radiol; 2011 Feb 04; 46(2):94-105. PubMed ID: 21139507
    [Abstract] [Full Text] [Related]

  • 17. Effectiveness of screening with annual magnetic resonance imaging and mammography: results of the initial screen from the ontario high risk breast screening program.
    Chiarelli AM, Prummel MV, Muradali D, Majpruz V, Horgan M, Carroll JC, Eisen A, Meschino WS, Shumak RS, Warner E, Rabeneck L.
    J Clin Oncol; 2014 Jul 20; 32(21):2224-30. PubMed ID: 24934793
    [Abstract] [Full Text] [Related]

  • 18. Added cancer yield of breast magnetic resonance imaging screening in women with a prior history of chest radiation therapy.
    Freitas V, Scaranelo A, Menezes R, Kulkarni S, Hodgson D, Crystal P.
    Cancer; 2013 Feb 01; 119(3):495-503. PubMed ID: 22952042
    [Abstract] [Full Text] [Related]

  • 19. Factors Associated with False Positive Results on Screening Mammography in a Population of Predominantly Hispanic Women.
    McGuinness JE, Ueng W, Trivedi MS, Yi HS, David R, Vanegas A, Vargas J, Sandoval R, Kukafka R, Crew KD.
    Cancer Epidemiol Biomarkers Prev; 2018 Apr 01; 27(4):446-453. PubMed ID: 29382701
    [Abstract] [Full Text] [Related]

  • 20. Supplemental Breast MR Imaging Screening of Women with Average Risk of Breast Cancer.
    Kuhl CK, Strobel K, Bieling H, Leutner C, Schild HH, Schrading S.
    Radiology; 2017 May 01; 283(2):361-370. PubMed ID: 28221097
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 59.